261
Views
2
CrossRef citations to date
0
Altmetric
Reviews

Formulation Aspects and Effect of Critical Factors for Designing Extended Release Pellets: An Updated Review

&

References

  • http://www.fda.gov/downloads/Drugs/Guidances/ucm070640.pdf (accessed Feb 2015).
  • de Haan, P.; Lerk, C.F. Oral controlled release dosage forms. A review. Pharm. Weekbl. 1984, 6, 57–67.
  • Kramer, J.; Blume, H. Biopharmaceutical aspects of multiparticulates. In: Ghebre-Sellassie, I. ed. Multiparticulate Oral Drug Delivery, Informa Health Care: New York, 1994; pp. 307–332.
  • Hoffman, A. Pharmacodynamic aspects of sustained release preparations. Adv. Drug. Del. Rev. 1998, 33, 185–199.
  • http://pharmtech.findpharma.com/pharmtech/data/articlestandard//pharmtech/232003/59302/article.pdf (accessed Nov 2008).
  • Ghai, D. Pelletization: An alternate to granulation. Pharma times 2011, 43, 13–15.
  • Ghebre-Sellassie, I. Pellets: A general overview. In: Ghebre-Sellassie, I. ed. Pharmaceutical Pelletization Technology, vol. 37, Marcel Dekker: New York, 1989; pp. 1–15.
  • Digenis, G.A. In vivo behavior of multiparticulate versus single-unit dose formulations. In: Ghebre-Sellassie, I. ed. Multiparticulate Oral Drug Delivery, Informa Health Care: New York, 1994; pp. 333–356.
  • http://www.initium.demon.co.uk/rel_nf.htm (accessed Nov 2008).
  • Bodmeier, R. Tableting of coated pellets. Eur. J. Pharm. Biopharm. 1997, 43, 1–8.
  • Gaber, D.M.; Nafee, N.; Abdallah, O.Y. Mini-tablets versus pellets as promising multiparticulate modified release delivery systems for highly soluble drugs. Int. J. Pharm. 2015, 5, 86–94
  • Wesseling, M.; Bodmeier, R. Influence of plasticization time, curing conditions, storage time, and core properties on the drug release from aquacoat-coated pellets. Pharm. Dev. Tech. 2001, 6, 325–331.
  • Chambin, O.; Champion, D.; Debray, C.; Rochat-Gonthier, M.H.; Le Meste, M.; Pourcelot, Y. Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage. J. Control. Release. 2004, 95, 101–108.
  • Ha, J.-M.; Kim, J.-Y.; Oh, T.-O.; Rhee, Y.-S.; Chi, S.-C.; Kuk, H.; Park, C.-W.; Park, E.-S. Preparation and evaluation of sustained-release doxazosin mesylate pellets. Chem. Pharm. Bull. 2013, 61, 371–378.
  • Varshosaz, J.; Emami, J.; Tavakoli, N.; Minaiyan, M.; Rahmani, N.; Dorkoosh, F. Development and evaluation of a novel pellet-based tablet system for potential colon delivery of budesonide. J. Drug Del. 2012, 1–7.
  • Dreu, R.; Luštrik, M.; Perpar, M.; Žun, I.; Srčič, S. Fluid-bed coater modifications and study of their influence on the coating process of pellets. Drug Dev. Ind. Pharm. 2012, 38, 501–511.
  • Mota, J. Matrix-sand reservoir-type oral multiparticulate drug delivery systems. Ph.D. Thesis, Freie Universitat Berlin, Germany, 2010; 2–161.
  • Ravella, V.N.; Nadendla, R.R.; Kesari, N.C. Design and evaluation of sustained release pellets of aceclofenac. J. Pharma. Res. 2013, 6, 525–531.
  • Tirpude, R.N.; Puranik, P.K. Rabeprazole sodium delayed-release multiparticulates: Effect of enteric coating layers on product performance. J. Adv. Pharm. Tech. Res. 2011, 2, 184–191.
  • Flament, M.P.; Dupont, G.; Leterme, P.; Farah, N.; Gayot, A. Development of 400 µm pellets by extrusion-spheronization application with Gelucire 50/02 to produce a “sprinkle” form. Drug Dev. Ind. Pharm. 2004, 30, 43–51.
  • Kachrimanis, K.; Nikolakakis, I.; Malamataris, S. Spherical crystal agglomeration of ibuprofen by the solvent-change technique in presence of methacrylic polymers. J. Pharm. Sci. 2000, 89, 250–259.
  • Paradkar, A.R.; Maheshwari, M.; Ketkar, A.R.; Chauhan, B. Preparation and evaluation of ibuprofen beads by melt solidification technique. Int. J. Pharm. 2003, 255, 33–42.
  • Knoch, A. Cryopelletization. In: Ghebre-Sellassie, I. ed. Multiparticulate Oral Drug Delivery, Informa Health Care: New York, 1994; pp. 35–50.
  • Glaessl, B.; Siepmann, F.; Tucker, I.; Siepmann, J.; Rades, T. Characterisation of quaternary polymethacrylate films containing tartaric acid, metoprolol free base or metoprolol tartrate. Eur. J. Pharm. Biopharm. 2009, 73, 366–372.
  • Huang, X.; Brazel, C.S. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J. Controlled Release 2001, 73, 121–136.
  • Murthy Dwibhashyam, V.S.N.; Vijaya Ratna, J. Key formulation variables in tableting of coated pellets. Indian. J. Pharm. Sci. 2008, 70, 555–564.
  • Scott, D.C.; Hollenbeck, R.G. Design and manufacture of a zero-order sustained-release pellet dosage form through nonuniform drug distribution in a diffusional matrix. Pharm. Res. 1991, 8, 156–61.
  • Abdul, S.; Chandewar, A.V.; Jaiswal, S.B. A flexible technology for modified-release drugs: Multiple-unit pellet system (MUPS). J. Control. Release. 2010, 147, 2–16.
  • Dey, N.S.; Majumdar, S.; Rao, M.E.B. Multiparticulate drug delivery systems for controlled release. Trop. J. Pharm. Res. 2008, 7, 1067–1075.
  • Chourasia, M.K.; Jain, S.K. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharmaceut. Sci. 2003, 6, 33–66.
  • Kim, J.; Park, C.; Lee, B.; Park, E.; Rhee, Y. Design and evaluation of nicorandil extended-release tablet. Asian J. Pharm. Sci. 2015, 10, 108–113.
  • Ige, P.; Rajput, P.; Pardeshi, C.; Mahajan, H.; Nerkar, P.; Belgamwar, V.; Surana, S.; Gattani, S. Development of pellets of nifedipine using HPMC K15 M and κ-carrageenan as mucoadhesive sustained delivery system and in vitro evaluation. Iran. Polym. J. 2013, 22, 911–921.
  • Lotlikar, V.; Kedar, U.; Shidhaye, S.; Kadam, V. pH-responsive dual pulse multiparticulate dosage form for treatment of rheumatoid arthritis. Drug. Dev. Ind. Pharm. 2010, 36, 1295–1302.
  • Brahmankar, D.M.; Jaiswal, S.B. Biopharmaceutics and pharmacokinetics a treatise, Vallabh Prakashan, Delhi, India, 2002; pp. 335–337.
  • Wen, H.; Park, K. Introduction and an overview of oral controlled release formulation design. In: Wen, H., Park, K. ed. Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice, John Wiley and Sons: Hoboken, NJ, 2010; pp. 1–19.
  • Zhang, H.; Jean M. Drug Delivery Theory to Practice Surian Biopharmaceutic Consideration and Assessment for Oral Controlled Release Formulations. John Wiley and Sons: Hoboken, NJ, 2010; pp. 33–45.
  • Hogan, J. Coating of tablets and multiparticulates. In: Aulton, M.E. ed. Pharmaceutics, the Science of Dosage Form Design, 2nd ed., Churchill Livingstone: Edinburgh, 2002; pp. 441–448.
  • Porter, S.C. Controlled-release film coatings based on ethylcellulose. Drug Dev. Ind. Pharm. 1989, 15, 1495–1521.
  • Pai, R.; Kohli, K.; Shrivastava, B. Compression and evaluation of extended release matrix pellets prepared by the extrusion/spheronization process into disintegrating tablets. Braz. J. Pharm. Sci. 2012, 48, 117–129.
  • Ahmed, I.; Islam, M.R.; Rahman, M.H. Delayed release pharmaceutical pellets having duloxetine hydrochloride containing core and acid resistant acrylic polymer based outer layer coat. Bang. Pharm. J. 2010, 13, 9–13.
  • Prasad, M.B.; Vidyadhara, S.; Sasidhar, R.L.; Balakrishna, T.; Trilochani, P. Development and evaluation of diltiazem hydrochloride controlled-release pellets by fluid bed coating process. J. Adv. Pharm. Technol. Res. 2013, 4, 101–107.
  • Sultana, S.; Khosru, K.H.; Al-Masud, A. Development and evaluation of in-vitro release kinetics of sustained release pellets of gliclazide using combinations of cellulose polymers. J. Pharm. Educ. Res. 2012, 3, 1–9.
  • Snejdrova, E.; Dittrich, M. Pharmaceutical applications of plasticized polymers. In: Luqman, M. ed. Recent Advances in Plasticizers. InTech: Europe, 2012, Chapter 4; pp. 69–90.
  • Zhu, Y.; Shah, N.H.; Malick, A.W.; Infeld, M.H.; McGinity, J.W. Solid-state plasticization of an acrylic polymer with chlorpheniramine maleate and triethyl citrate. Int. J. Pharm. 2002, 241, 301–310.
  • Rahman, M.; Brazel, C.S. The plasticizer market: an assessment of traditional plasticizers and research trends to meet new challenges. Pro. Poly. Sci. 2004, 29, 1223–1248.
  • Chamarthy, S.P.; Pinal, R. Moisture induced antiplasticization in microcrystalline cellulose compacts. Tab. Cap. 2007, 5, 22–33.
  • Bodmeier, R.; Paeratakul, O. Leaching of water-soluble plasticizers from polymeric films prepared from aqueous colloidal polymer dispersions. Drug Dev. Ind. Pharm. 1992, 18, 1865–1882.
  • Lippold, B.C.; Lippold, B.H.; Sutter, B.K.; Gunder, W. Properties of aqueous, plasticizer-containing ethyl cellulose dispersions and prepared films in respect to the production of oral extended release formulations. Drug Dev. Ind. Pharma. 2008, 16, 1725–1747.
  • Siepmann, J.; Paeratakul, O.; Bodmeier, R. Modeling plasticizer uptake in aqueous polymer dispersions. Int. J. Pharm. 1998, 165, 191–200.
  • Yang, Q.W.; Flament, M.P.; Siepmann, F.; Busignies, V.; Leclerc, B.; Herry, C.; Tchoreloff, P.; Siepmann, J. Curing of aqueous polymeric film coatings: Importance of the coating level and type of plasticizer. Eur. J. Pharm. Biopharm. 2010, 74, 362–370.
  • Wang, C.C.; Zhang, G.; Shah, N.H.; Infeld, M.H.; Malick, A.W.; McGinity, J.W. Influence of plasticizers on the mechanical properties of pellets containing Eudragit® RS 30 D. Int. J. Pharm. 1997, 152, 153–163.
  • Kibria, G.; Roni, M.A.; Absar, M.S.; Jalil, R. Effect of plasticizer on release kinetics of diclofenac sodium pellets coated with Eudragit RS 30 D. AAPS. AAPS PharmSciTech 2008, 9, 1224–1246.
  • Breitenbach, J. Melt extrusion: From process to drug delivery technology. Eur. J. Pharm. Biopharm. 2002, 54, 107–117.
  • Repka, M.A.; Battu, S.K.; Upadhye, S.B.; Thumma, S.; Crowley, M.M.; Zhang, F.; Martin, C.; McGinity, J.W. Pharmaceutical applications of hot-melt extrusion: Part II. Drug Dev. Ind. Pharm. 2007, 33, 1043–1057.
  • Schilling, S.U.; Lirola, H.L.; Shah, N.H.; Malick, A.W.; McGinity, J.W. Influence of plasticizer type and level on the properties of Eudragit® S100 matrix pellets prepared by hot-melt extrusion. J. Microencapsulation 2010, 27, 521–532.
  • Roblegg, E.; Ulbing, S.; Zeismann, S.; Zimmer, A. Development of lipophilic calcium stearate pellets using ibuprofen as model drug. Eur. J. Pharm. Biopharm. 2010, 75, 56–62.
  • Schilling, S.U.; Shah, N.H.; Malick, A.W.; McGinity, J.W. Properties of melt extruded enteric matrix pellets. Eur. J. Pharm. Biopharm. 2010, 74, 352–361.
  • Snejdrova, E.; Dittrich, M. Pharmaceutically used plasticizers. In: Luqman, M. ed. Recent Advances in Plasticizers, InTech: Europe, 2012, Chapter 3; pp. 45–65.
  • Kucera, S.A., McGinity, J.W., Felton, L.A. Physical aging of polymers and its effect on the stability of solid oral dosage forms. In: McGinity, J.W., Felton, L.A. ed. Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, Informa Healthcare: New York, 2008; pp. 445–474.
  • Hutchings, D.; Clarson, S.; Sakr, A. Studies of the mechanical properties of free films prepared using an ethylcellulose pseudolatex coating system. Int. J. Pharm. 1994, 104, 203–213.
  • Crawford, R.R.; Esmerian, O.K. Effect of plasticizers on some physical properties of cellulose acetate phthalate films. J. Pharm. Sci. 1971, 60, 312–314.
  • Johnson, K.; Hathaway, R.; Leung.P.; Franz, R. Effect of triacetin and polyethylene glycol 400 on some physical properties of hydroxypropyl methylcellulose free films. Int. J. Pharm. 1991, 73, 197–208.
  • Turner, D.T.; Abell, A.K. Water sorption of poly (methyl methacrylate): 2. Effects of crosslinks. Polymer 1987, 28, 297–302.
  • Thoma, K.; Bechtold, K. Influence of aqueous coatings on the stability of enteric coated pellets and tablets. Eur. J. Pharm. Biopharm. 1999, 47, 39–50.
  • Saettone, M.F.; Perini, G.; Rijli, P.; Rodriguez, L.; Cini, M. Effect of different polymer-plasticizer combinations on ‘in vitro’ release of theophylline from coated pellets. Int. J. Pharm. 1995, 126, 83–88.
  • Hutchings, D.E.; Sakr, A. Influence of pH and plasticizers on drug release from ethylcellulose pseudolatex coated pellets. J. Pharma. Sci. 1994, 83, 1386–1390.
  • Bando, H.; McGinity, J.W. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit® S100:L100 dispersion. Int. J. Pharma. 2006, 323, 11–17.
  • Kadajji, V.G.; Betageri, G.V. Water soluble polymers for pharmaceutical applications. Poly. 2011, 3, 1972–2009.
  • http://www.pharmainfo.net/binders (accessed on Nov 2015).
  • Garekani, H.A.; Nokhodchi, A.; Rayeni, M.A.; Sadeghi, F. Preparation and characterization and release properties of Eudragit RS based ibuprofen pellets prepared by extrusion spheronization: Effect of binder type and concentration. Drug Dev. Ind. Pharm. 2013, 39, 1238–1246.
  • Akhgari, A.; Abbaspour, M.R.; Pirmoradi, S. Preparation and evaluation of pellets using acacia and tragacanth by extrusion-spheronization. Daru, J. Pharma. Sci. 2011, 19, 417–423.
  • Sadeghi, F.; Ford, J.L.; Rubinstein, M.H.; Rajabi-Siahboomi, A.R. Comparative study of drug release from pellets coated with HPMC or Surelease. Drug Dev. Ind. Pharm. 2000, 26, 651–660.
  • Ye, Z.; Rombout, P.; Remon, J.P.; Vervaet, C.; Mooter, G.V. Plasticized isolated ethyl cellulose/hydroxyl propyl methylcellulose films and drug release from reservoir pellets. Eur. J. Pharm. Biopharm. 2007, 67, 485–490.
  • http://www.colorcon.com/literature/marketing/mr/ExtendedRelease/ETHOCEL/Chinese/ The Influence of Pore Former on Drug Release from Ethylcellulose Coated Multiparticulates (accessed 28 Nov 2015).
  • http://www.colorcon.com/literature/marketing/mr/ExtendedRelease/Surelease/Englih/hypromellose_pore_former.pdf (accessed 28 Nov 2015).
  • Dulin, W. Oral targeted drug delivery systems: Enteric coating. In: Wen, H., Park, K. ed. Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice. John Wiley and Sons Inc.: NJ, Canada, 2010; pp. 1–20.
  • Hamedelniel, E.I.; Bajdik, J.; Sovany, T.; Pintye-Hodi, K. Delayed release matrix pellet preparation containing an alkalizing pore-former agent. Chem. Eng. Res. Des. 2011, 89, 1006–1010.
  • Ige, P.P.; Gattani, S.G. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: A technical note. Arch. Pharmacal Res. 2012, 35, 487–498.
  • Mayo-Pedrosa, M.; Cachafeiro-Andrade, N.; Alvarez-Lorenzo, C.; Martinez-Pacheco, R.; Concheiro, A. In situ photopolymerization-coated pellets for pH-dependent drug delivery. Eur. Polym. J. 2008, 44, 2629–2638.
  • Thoma, K.; Ziegler, I. The pH-independent release of fenoldopam from pellets with insoluble film coats. Eur. J. Pharm. Biopharm. 1998, 46, 105–113.
  • Ploen, J.; Andersch, J.; Heschel, M.; Leopold, C.S. Citric acid as a pH-modifying additive in an extended release pellet formulation containing a weakly basic drug. Drug Dev. Ind. Pharm. 2009, 35, 1210–1218.
  • Xu, L.; Luo, Y.; Feng, J.; Xu, M.; Tao, X.; He, H.; Tang, X. Preparation and in vitro–in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability. Int. J. Pharm. 2012, 422, 9–16.
  • Padhy, K.K.; Swain, K.; Chowdary, K.A. Influence of organic acids on drug release pattern of verapamil hydrochloride pellets. J. Adv. Pharm. Res. 2010; 1, 65–73.
  • Petereit, H.U.; Assmus, M.; Lehmann, K. Glyceryl monostearate as a glidant in aqueous film-coating formulations. Eur. J. Pharm. Biopharm. 1995, 41, 219–228.
  • Wesseling, M.; Bodmeier, R. Drug release from beads coated with an aqueous colloidal ethylcellulose dispersion, aquacoat®, or an organic ethylcellulose solution. Eur. J. Pharm. Biopharm. 1999, 47, 33–38.
  • Eskandari, S.; Varshosaz, J.; Akhavanfarid, G.; Hafizi, G. Formulation and in-vitro characterization of extended release pellets of indomethacin using powder-layering technique. Res. Pharma. Sci. 2007, 2, 67–75.
  • http://www.emersonresources.com (accessed 28 Nov 2015).
  • El-Malah, Y.; Nazzal, S. Effect of Eudragit® RS 30D and talc powder on Verapamil hydrochloride release from beads coated with drug layered matrices. AAPS PharmSciTech 2008, 9, 75–83.
  • Hileman, G.A.; Upadrashta, S.M.; Neau, S.H. Drug solubility effects on predicting optimum conditions for extrusion and spheronization of pellets. Pharm. Dev. Technol. 1997, 2, 43–52.
  • Thoma, K.; Ziegler, I. Investigations on the influence of the type of extruder for pelletization by extrusion-spheronization. II. Sphere characteristics. Drug Dev. Ind. Pharm. 1998, 24, 413–422.
  • Kibria, G.; Islam, K.A.; Jalil, R. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer. Pak. J. Pharm. Sci. 2009, 22, 36–43.
  • Hamedelniel, E.I.; Bajdik, J.; Sovany, T.; Kasa, P., Jr.; Pintye-Hodi, K. Effects of the wetting liquid and ethylcellulose on the properties of atenolol-containing pellets. Drug Delivery Sci. Technol. 2011, 21, 195–200.
  • Hamedelniel, E.I.; Bajdik, J.; Pintye-Hodi, K. Optimization of preparation of matrix pellets containing ethylcellulose. Chem. Eng. Process. 2010, 49, 120–124.
  • Sriamornsak, P.; Nunthanid, J.; Luangtana-anan, M.; Puttipipatkhachorn, S. Alginate-based pellets prepared by extrusion/spheronization: A preliminary study on the effect of additive in granulating liquid. Eur. J. Pharm. Biopharm. 2007, 67, 227–235.
  • Lustig-Gustafsson, C.; Johal, H.K.; Podczeck, F.; Newton, J.M. The influence of water content and drug solubility on the formulation of pellets by extrusion and spheronisation. Eur. J. Pharm. Sci. 1999, 8, 147–152.
  • Boutell, S.; Newton, J.M.; Bloor, J.R.; Hayes, G. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization. Int. J. Pharm. 2002, 238, 61–76.
  • http://www.google.com/patents/WO2004047799A2?cl=en (accessed 28 Nov 2015).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.